Matrix-associated Autologous Chondrocyte Implant vs. Periosteal Flap Implant .
OrthoEvidence Journal (OE Journal) - ACE Report
OE Journal. 2013;1(9):68 Am J Sports Med. 2010 May;38(5):924-33. Epub 2009 Dec 421 patients with symptomatic isolated full-thickness cartilage defects (4.1 +/- 0.09 cm2) at the femoral condyle were randomized to undergo either the matrix-associated autologous chrondocyte implantation (m-ACI) or periosteal flap autologous chrondocyte implantation (ACI-P). At 1 and 2 years follow up, the cartilage repair via matrix-associated autologous chondrocyte implant (m-ACI) was found equivalent in efficacy compared to earlier generation autologous chondrocyte implantation using periosteal flap technique.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
Are you affiliated with one of our partner associations?
Click here to gain complimentary access as part your association member benefits!